These innovative treatments, Semaglutide , represent a groundbreaking advancement in treating metabolic dysfunction and conceivably associated conditions . These drugs are categorized as GLP-1 receptor agonists , signifying they to replicate the endogenous GLP-1 substance , stimulating metabolic production and suppressing food intake. Despite Retat